Trastuzumab Injection 150mg | 440mg

Description

Trastuzumab Injection

• Product Overview
Trastuzumab Injection is a recombinant humanized monoclonal antibody anticancer therapy used for the treatment of HER2-positive cancers. It works by specifically targeting the HER2 (Human Epidermal Growth Factor Receptor 2) protein present on certain cancer cells, helping inhibit tumor cell growth and survival.

Trastuzumab Injection is administered by intravenous infusion under the supervision of an oncologist or qualified healthcare professional.

• Available Strengths
– Trastuzumab 150 mg Injection
– Trastuzumab 440 mg Injection

• Therapeutic Category
Anticancer Agent / Monoclonal Antibody / HER2 Inhibitor

• Indications
Trastuzumab Injection is indicated for:
– HER2-Positive Breast Cancer
– Early-Stage HER2-Positive Breast Cancer (as prescribed)
– Metastatic Breast Cancer
– HER2-Positive Gastric Cancer
– Gastroesophageal Junction Cancer
– Other Approved HER2-Positive Cancer Indications

• Common Side Effects
Some patients may experience:
– Infusion-related reactions
– Fever and chills
– Fatigue
– Nausea
– Diarrhea
– Headache
– Muscle or joint pain

• Serious Side Effects
Seek immediate medical attention if any of the following occur:
– Heart function problems (cardiomyopathy, reduced ejection fraction)
– Severe infusion reactions
– Severe lung-related complications
– Severe allergic reactions

• Precautions
– Use only under oncologist supervision.
– Cardiac function assessment is recommended before and during treatment.
– Monitor for infusion-related reactions.
– Use cautiously in patients with heart disease.
– Maintain required cold chain storage conditions.
– Store refrigerated at 2°C–8°C. Do not freeze.

• Technical Information

• Active Ingredient
– Trastuzumab:
– 150 mg
– 440 mg

• Mechanism of Action
Trastuzumab binds selectively to the HER2 receptor on cancer cells, inhibiting HER2 signaling pathways and activating immune-mediated destruction of tumor cells.

• Dosage Form
Sterile Lyophilized Powder for Concentrate for Infusion

• Route of Administration
Intravenous (IV) Infusion

• Shelf Life
24–36 Months (depending on packaging and regulatory requirements)

• Storage Conditions
Store at 2°C–8°C, protected from light. Do not freeze.

• Product Specifications
Product Name:- Trastuzumab Injection
Generic Name:- Trastuzumab
Strength:- 150 mg / 440 mg
Dosage Form:- Sterile Lyophilized Powder for Infusion
Category:- Oncology / Monoclonal Antibody
Packaging:- Glass Vial / Customized Export Packing
Pack Size:- 1 Vial
Shelf Life:- 24–36 Months
Storage:- 2°C–8°C
Origin:- India

• Regulatory Status & Supply Information
– Manufactured in WHO-GMP compliant facilities.
– Available for international oncology markets (subject to importing country regulations).
– Export documentation support available.
– Private Label Manufacturing available where permitted.
– Third-Party Manufacturing available.
– Customized export packaging available.
– Cold chain supply support as per requirement.
– Bulk supply available for oncology distributors, hospitals, cancer centers, and government tenders.

• Who Should Source This Product?
This product is ideal for:
– Pharmaceutical Importers
– Oncology Product Distributors
– Cancer Treatment Centers
– Hospital Procurement Companies
– Government Healthcare Programs
– Tender Suppliers
– Specialty Medicine Suppliers

• Why Source From Mediora Exports?
– Trusted Pharmaceutical Exporter from India
– WHO-GMP Manufacturing Partners
– Competitive International Pricing
– Wide Oncology Product Portfolio
– Reliable Global Supply Chain
– Flexible Packaging Options
– Complete Export Documentation Support

• Contact Details
Mediora Exports

📧 Email: info@medioraexports.com
📱 Phone/WhatsApp: +91 99047 64844